Monkeypox virus (MPXV): A Brief account of global spread, epidemiology, virology, clinical features, pathogenesis, and therapeutic interventions
- PMID: 38205182
- PMCID: PMC10774656
- DOI: 10.1016/j.imj.2023.11.001
Monkeypox virus (MPXV): A Brief account of global spread, epidemiology, virology, clinical features, pathogenesis, and therapeutic interventions
Abstract
The largest monkeypox virus (MPXV) outbreak of the 21st century occurred in 2022, which caused epidemics in many countries. According to WHO, physical contact with infected persons, contaminated surfaces, or affected animals might be a source of this virus transmission. A febrile sickness including few symptoms found in MPX disease. Skin rash, lesions, fever, headache, fatigue, and muscle aches symptoms were observed commonly for this disease. Animal and in vitro, studies have shown that the antiviral medications cidofovir and brincidofovir are effective against MPXV. The first-generation vaccinia virus vaccine was developed in 1960, and it helped to protect against MPXV with its side effects. A second-generation vaccination with limitations was launched in 2000. However, the CDC advised vaccinations for risk groups in endemic countries, including positive patients and hospital employees. The JYNNEOS vaccine, administered in 2 doses, also provides protection from MPX. This article presents concisely the most recent findings regarding epidemiology, genomic transmission, signs and symptoms, pathogenesis, diagnosis, and therapeutic interventions for MPXV, which may be helpful to researchers and practitioners. WHO declared that MPX was no longer a global health emergency due to its declining case rate, and a number of countries have reported new incidences. Further research-based investigations must be carried out based on the 2022 outbreak.
Keywords: Epidemiology; Genomic dissemination; Monkeypox (MPX); Monkeypox virus (MPXV); Re-emerging viruses; Vaccination and Treatment; Zoonotic diseases.
© 2023 The Author(s).
Figures



Similar articles
-
The Global Human Monkeypox Outbreak and Management: A Comprehensive Literature Review.Cureus. 2022 Dec 15;14(12):e32557. doi: 10.7759/cureus.32557. eCollection 2022 Dec. Cureus. 2022. PMID: 36654643 Free PMC article. Review.
-
Monkeypox virus: a re-emergent threat to humans.Virol Sin. 2022 Aug;37(4):477-482. doi: 10.1016/j.virs.2022.07.006. Epub 2022 Jul 9. Virol Sin. 2022. PMID: 35820590 Free PMC article. Review.
-
Human Monkeypox: A Comprehensive Overview of Epidemiology, Pathogenesis, Diagnosis, Treatment, and Prevention Strategies.Pathogens. 2023 Jul 18;12(7):947. doi: 10.3390/pathogens12070947. Pathogens. 2023. PMID: 37513794 Free PMC article. Review.
-
Comprehensive overview of human monkeypox: epidemiology, clinical features, pathogenesis, diagnosis and prevention.Ann Med Surg (Lond). 2023 May 3;85(6):2767-2773. doi: 10.1097/MS9.0000000000000763. eCollection 2023 Jun. Ann Med Surg (Lond). 2023. PMID: 37363539 Free PMC article.
-
Low levels of monkeypox virus-neutralizing antibodies after MVA-BN vaccination in healthy individuals.Nat Med. 2023 Jan;29(1):270-278. doi: 10.1038/s41591-022-02090-w. Epub 2022 Oct 18. Nat Med. 2023. PMID: 36257333 Free PMC article.
Cited by
-
Novel drug targets for monkeypox: From viral to host proteins.Infect Med (Beijing). 2025 Jan 13;4(1):100165. doi: 10.1016/j.imj.2025.100165. eCollection 2025 Mar. Infect Med (Beijing). 2025. PMID: 40026317 Free PMC article.
-
Assessment of knowledge and awareness of monkeypox viral infection in Palestine: a community-based study.Front Cell Infect Microbiol. 2025 Aug 1;15:1584848. doi: 10.3389/fcimb.2025.1584848. eCollection 2025. Front Cell Infect Microbiol. 2025. PMID: 40822577 Free PMC article.
-
Transcriptomic and Proteomic Analysis of Monkeypox Virus A5L-Expressing HEK293T Cells.Int J Mol Sci. 2025 Jan 5;26(1):398. doi: 10.3390/ijms26010398. Int J Mol Sci. 2025. PMID: 39796253 Free PMC article.
-
A Comparative Evaluation of Three Diagnostic Assays for the Detection of Human Monkeypox.Viruses. 2024 Aug 12;16(8):1286. doi: 10.3390/v16081286. Viruses. 2024. PMID: 39205260 Free PMC article.
-
Mpox: An emerging or re-emerging infection with a potential colossal burden on healthcare globally.Afr J Lab Med. 2025 May 31;14(1):2644. doi: 10.4102/ajlm.v14i1.2644. eCollection 2025. Afr J Lab Med. 2025. PMID: 40470132 Free PMC article. Review.
References
Publication types
LinkOut - more resources
Full Text Sources